These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2331614)

  • 1. Anatomic evidence for a neurotoxic effect of (+/-)-fenfluramine upon serotonergic projections in the rat.
    Molliver DC; Molliver ME
    Brain Res; 1990 Mar; 511(1):165-8. PubMed ID: 2331614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.
    Mamounas LA; Mullen CA; O'Hearn E; Molliver ME
    J Comp Neurol; 1991 Dec; 314(3):558-86. PubMed ID: 1814975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA).
    Mamounas LA; Molliver ME
    Exp Neurol; 1988 Oct; 102(1):23-36. PubMed ID: 2846339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies.
    Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):928-43. PubMed ID: 2732954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of short- and long-term effects of DL-fenfluramine on the serotonergic innervation of the rat hippocampal formation.
    Sotelo C
    Brain Res; 1991 Feb; 541(2):309-26. PubMed ID: 2054644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.
    Callahan BT; Cord BJ; Ricaurte GA
    Synapse; 2001 May; 40(2):113-21. PubMed ID: 11252022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity of MDMA and related compounds: anatomic studies.
    Molliver ME; Berger UV; Mamounas LA; Molliver DC; O'Hearn E; Wilson MA
    Ann N Y Acad Sci; 1990; 600():649-61; discussion 661-4. PubMed ID: 1979216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons.
    Kalia M
    Brain Res; 1991 May; 548(1-2):111-25. PubMed ID: 1868326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1990 May; 36(1):105-9. PubMed ID: 2140899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regeneration of d,l-fenfluramine-destroyed serotonergic nerve terminals.
    Westphalen RI; Dodd PR
    Eur J Pharmacol; 1993 Jul; 238(2-3):399-402. PubMed ID: 8405109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial response to degeneration of serotonergic axon terminals.
    Wilson MA; Molliver ME
    Glia; 1994 May; 11(1):18-34. PubMed ID: 8070892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.
    Hatzidimitriou G; Tsai EH; McCann UD; Ricaurte GA
    Synapse; 2002 Apr; 44(1):51-7. PubMed ID: 11842446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent interactive changes in serotonergic and noradrenergic cortical axon terminals in F344 rats.
    Nakai S; Matsunaga W; Isobe K; Shirokawa T
    Neurosci Res; 2006 Mar; 54(3):220-9. PubMed ID: 16406149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenedioxyamphetamine: neurotoxic effects on serotonergic projections to brainstem nuclei in the rat.
    Harvey JA; McMaster SE; Romano AG
    Brain Res; 1993 Aug; 619(1-2):1-14. PubMed ID: 7690669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain.
    Axt KJ; Molliver ME
    Synapse; 1991 Dec; 9(4):302-13. PubMed ID: 1722593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat strain differences in the vulnerability of serotonergic nerve endings to neurotoxic damage by p-chloroamphetamine.
    Zhou D; Schreinert M; Pilz J; Huether G
    J Neural Transm (Vienna); 1996; 103(12):1381-95. PubMed ID: 9029405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurotoxic effects of p-chloroamphetamine in rat brain are blocked by prior depletion of serotonin.
    Berger UV; Grzanna R; Molliver ME
    Brain Res; 1992 Apr; 578(1-2):177-85. PubMed ID: 1511276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.